Greenwich Lifesciences Inc GLSI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:27 PM EDT
9.42quote price arrow up+0.57 (+6.44%)
Volume
231,798
52 week range
6.82 - 48.96
Loading...
  • Open9.28
  • Day High10.25
  • Day Low8.72
  • Prev Close8.85
  • 52 Week High48.96
  • 52 Week High Date06/30/21
  • 52 Week Low6.82
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap122.46M
  • Shares Out13.00M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.83

KEY STATS

  • Open9.28
  • Day High10.25
  • Day Low8.72
  • Prev Close8.85
  • 52 Week High48.96
  • 52 Week High Date06/30/21
  • 52 Week Low6.82
  • 52 Week Low Date06/13/22
  • Market Cap122.46M
  • Shares Out13.00M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.83

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-20.79
  • Fwd P/E (NTM)-12.56
  • EBITDA (TTM)-5.983M
  • ROE (TTM)-24.13%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/13/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Greenwich Lifesciences Inc

There is no recent news for this security.

Profile

MORE
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 will be delivered in combination with...
David McWilliams
Independent Chairman of the Board
Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Jaye Thompson Ph.D.
Vice President - Clinical & Regulatory Affairs
Address
3992 Bluebonnet Dr, Building 14
Stafford, TX
77477
United States

Top Peers

SYMBOLLASTCHG%CHG
TCRR
TCR2 Therapeutics Inc
2.93+0.04+1.38%
CAPR
Capricor Therapeutics Inc
3.90-0.51-11.56%
VIRX
Viracta Therapeutics Inc
3.35+0.11+3.23%
EVLO
Evelo Biosciences Inc
2.21-0.01-0.45%
IMUX
Immunic Inc
3.93-0.03-0.76%